Page last updated: 2024-09-03

24-hydroxycholesterol and Disease Exacerbation

24-hydroxycholesterol has been researched along with Disease Exacerbation in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (25.00)29.6817
2010's6 (75.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Austin, CP; Berry-Kravis, E; Bianconi, S; Brewer, CC; Davidson, CD; Farhat, NY; Jiang, X; Kao, M; Keener, LA; King, KA; Machielse, BN; McKew, JC; Ory, DS; Ottinger, EA; Pavan, WJ; Porter, FD; Rao, R; Sidhu, R; Silber, SA; Soldatos, A; Solomon, B; Thurm, A; Vite, CH; Walkley, SU; Walters, KA; Weissfeld, L; Xu, X1
Abrescia, P; De Mase, A; Di Natale, C; Monaco, A; Netti, PA; Pedone, C; Tedeschi, G; Tessitore, A1
Di Donato, S; Leoni, V; Long, JD; Mills, JA; Paulsen, JS1
Biasi, F; Gamba, P; Gargiulo, S; Giaccone, G; Guglielmotto, M; Iuliano, L; Leonarduzzi, G; Mauro, A; Monteleone, D; Poli, G; Tamagno, E; Testa, G; Zerbinati, C1
Jamnongkan, W; Jusakul, A; Khenjanta, C; Loilome, W; Namwat, N; Pairojkul, C; Techasen, A; Thanan, R; Yongvanit, P1
Bachi, A; Bernardi, R; Bordignon, C; Coltella, N; Corna, G; Crocchiolo, R; Doglioni, C; Gustafsson, JÅ; Invernizzi, F; Lin, CY; Maggioni, D; Moresco, M; Raccosta, L; Restuccia, U; Russo, V; Soncini, M; Traversari, C1
Björkhem, I; Cattaneo, E; Di Donato, S; Grisoli, M; Henley, SM; Hobbs, NZ; Leoni, V; Mandelli, ML; Mariotti, C; Tabrizi, SJ; Valenza, M; Wild, EJ1
Björkhem, I; De Luca, G; Diczfalusy, U; Hillert, J; Leoni, V; Masterman, T1

Trials

1 trial(s) available for 24-hydroxycholesterol and Disease Exacerbation

ArticleYear
Intrathecal 2-hydroxypropyl-β-cyclodextrin decreases neurological disease progression in Niemann-Pick disease, type C1: a non-randomised, open-label, phase 1-2 trial.
    Lancet (London, England), 2017, Oct-14, Volume: 390, Issue:10104

    Topics: 2-Hydroxypropyl-beta-cyclodextrin; Adolescent; Biomarkers; Calbindins; Child; Child, Preschool; Disease Progression; Dose-Response Relationship, Drug; Fatty Acid Binding Protein 3; Female; Hearing Loss, High-Frequency; Humans; Hydroxycholesterols; Injections, Spinal; Male; Niemann-Pick Disease, Type C; Rare Diseases; Young Adult

2017

Other Studies

7 other study(ies) available for 24-hydroxycholesterol and Disease Exacerbation

ArticleYear
The level of 24-hydroxycholesteryl esters decreases in plasma of patients with Parkinson's disease.
    Neuroscience letters, 2018, 04-13, Volume: 672

    Topics: Aged; Aged, 80 and over; Biomarkers; Disease Progression; Esters; Female; Humans; Hydroxycholesterols; Male; Middle Aged; Parkinson Disease

2018
Plasma 24S-hydroxycholesterol correlation with markers of Huntington disease progression.
    Neurobiology of disease, 2013, Volume: 55

    Topics: Adult; Cognition Disorders; Disability Evaluation; Disease Progression; Female; Gas Chromatography-Mass Spectrometry; Humans; Huntington Disease; Hydroxycholesterols; International Cooperation; Longitudinal Studies; Male; Middle Aged; Neuropsychological Tests; Statistics as Topic; Verbal Learning

2013
Up-regulation of β-amyloidogenesis in neuron-like human cells by both 24- and 27-hydroxycholesterol: protective effect of N-acetyl-cysteine.
    Aging cell, 2014, Volume: 13, Issue:3

    Topics: Acetylcysteine; Alzheimer Disease; Amyloid beta-Peptides; Cell Line, Tumor; Disease Progression; Humans; Hydroxycholesterols; Neurons; Oxidative Stress; Up-Regulation

2014
Association of CYP39A1, RUNX2 and oxidized alpha-1 antitrypsin expression in relation to cholangiocarcinoma progression.
    Asian Pacific journal of cancer prevention : APJCP, 2014, Volume: 15, Issue:23

    Topics: alpha 1-Antitrypsin; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Blotting, Western; Cell Line, Tumor; Cholangiocarcinoma; Core Binding Factor Alpha 1 Subunit; Disease Progression; Female; Humans; Hydroxycholesterols; Immunohistochemistry; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Oxidation-Reduction; Oxidative Stress; Prognosis; Steroid Hydroxylases

2014
24-Hydroxycholesterol participates in pancreatic neuroendocrine tumor development.
    Proceedings of the National Academy of Sciences of the United States of America, 2016, 10-11, Volume: 113, Issue:41

    Topics: Animals; Cell Transformation, Neoplastic; Cholestanetriol 26-Monooxygenase; Cholesterol 24-Hydroxylase; Cytokines; Disease Models, Animal; Disease Progression; Enzyme Activation; Female; Fluorescent Antibody Technique; Gene Expression; Gene Expression Regulation, Neoplastic; GTPase-Activating Proteins; Hydroxycholesterols; Hypoxia-Inducible Factor 1, alpha Subunit; Immunohistochemistry; Male; Mice; Mice, Transgenic; Neovascularization, Pathologic; Neuroendocrine Tumors; Pancreatic Neoplasms; Vascular Endothelial Growth Factor A

2016
Plasma 24S-hydroxycholesterol and caudate MRI in pre-manifest and early Huntington's disease.
    Brain : a journal of neurology, 2008, Volume: 131, Issue:Pt 11

    Topics: Adult; Biomarkers; Brain Mapping; Caudate Nucleus; Cholesterol; Cohort Studies; Disease Progression; Female; Gas Chromatography-Mass Spectrometry; Humans; Huntington Disease; Hydroxycholesterols; Magnetic Resonance Imaging; Male; Middle Aged; Prognosis; Young Adult

2008
Changes in human plasma levels of the brain specific oxysterol 24S-hydroxycholesterol during progression of multiple sclerosis.
    Neuroscience letters, 2002, Oct-18, Volume: 331, Issue:3

    Topics: Adult; Age Factors; Aged; Disease Progression; Female; Humans; Hydroxycholesterols; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Sclerosis; Radiography

2002